146 related articles for article (PubMed ID: 7815278)
1. Nasal absorption of desmopressin in rats and sheep. Effect of a bioadhesive microsphere delivery system.
Critchley H; Davis SS; Farraj NF; Illum L
J Pharm Pharmacol; 1994 Aug; 46(8):651-6. PubMed ID: 7815278
[TBL] [Abstract][Full Text] [Related]
2. Effects of viscous hyaluronate-sodium solutions on the nasal absorption of vasopressin and an analogue.
Morimoto K; Yamaguchi H; Iwakura Y; Morisaka K; Ohashi Y; Nakai Y
Pharm Res; 1991 Apr; 8(4):471-4. PubMed ID: 1871041
[TBL] [Abstract][Full Text] [Related]
3. Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides.
Illum L; Fisher AN; Jabbal-Gill I; Davis SS
Int J Pharm; 2001 Jul; 222(1):109-19. PubMed ID: 11404037
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the degradation of desamino1,D-arginine8-vasopressin by nasal mucosa.
Jönsson K; Alfredsson K; Söderberg-Ahlm C; Critchley H; Broeders A; Ohlin M
Acta Endocrinol (Copenh); 1992 Jul; 127(1):27-32. PubMed ID: 1519419
[TBL] [Abstract][Full Text] [Related]
5. Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin.
Harris AS; Ohlin M; Svensson E; Lethagen S; Nilsson IM
J Pharm Sci; 1989 Jun; 78(6):470-1. PubMed ID: 2760821
[TBL] [Abstract][Full Text] [Related]
6. Effects of concentration and volume on nasal bioavailability and biological response to desmopressin.
Harris AS; Ohlin M; Lethagen S; Nilsson IM
J Pharm Sci; 1988 Apr; 77(4):337-9. PubMed ID: 3379594
[TBL] [Abstract][Full Text] [Related]
7. In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate.
Bortolotti F; Balducci AG; Sonvico F; Russo P; Colombo G
Eur J Pharm Sci; 2009 Apr; 37(1):36-42. PubMed ID: 19162181
[TBL] [Abstract][Full Text] [Related]
8. Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats.
Balducci AG; Ferraro L; Bortolotti F; Nastruzzi C; Colombo P; Sonvico F; Russo P; Colombo G
Int J Pharm; 2013 Jan; 440(2):154-60. PubMed ID: 23046665
[TBL] [Abstract][Full Text] [Related]
9. Clinical study shows improved absorption of desmopressin with novel formulation.
Fransén N; Bredenberg S; Björk E
Pharm Res; 2009 Jul; 26(7):1618-25. PubMed ID: 19296208
[TBL] [Abstract][Full Text] [Related]
10. Preparation of desmopressin-containing liposomes for intranasal delivery.
Law SL; Huang KJ; Chou HY
J Control Release; 2001 Feb; 70(3):375-82. PubMed ID: 11182207
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of pharmacodynamics and bioavailability of 2 different desmopressin nasal sprays.
Eller N; Kollenz CJ; Hitzenberger G
Int J Clin Pharmacol Ther; 1998 Mar; 36(3):139-45. PubMed ID: 9562229
[TBL] [Abstract][Full Text] [Related]
12. Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin.
Harris AS; Nilsson IM; Wagner ZG; Alkner U
J Pharm Sci; 1986 Nov; 75(11):1085-8. PubMed ID: 3102719
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Estimation of the Effect of Nasal Mucociliary Function on in Vivo Absorption of Norfloxacin after Intranasal Administration to Rats.
Inoue D; Kimura S; Kiriyama A; Katsumi H; Yamamoto A; Ogawara KI; Higaki K; Tanaka A; Yutani R; Sakane T; Furubayashi T
Mol Pharm; 2018 Oct; 15(10):4462-4469. PubMed ID: 30165013
[TBL] [Abstract][Full Text] [Related]
14. A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations.
Joukhadar C; Schenk B; Kaehler ST; Kollenz CJ; Bauer P; Müller M; Eichler HG
Eur J Clin Pharmacol; 2003 Nov; 59(8-9):631-6. PubMed ID: 14564429
[TBL] [Abstract][Full Text] [Related]
15. Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems.
Charlton ST; Davis SS; Illum L
Int J Pharm; 2007 Jun; 338(1-2):94-103. PubMed ID: 17337137
[TBL] [Abstract][Full Text] [Related]
16. The relationship between in vivo nasal drug clearance and in vitro nasal mucociliary clearance: Application to the prediction of nasal drug absorption.
Inoue D; Tanaka A; Kimura S; Kiriyama A; Katsumi H; Yamamoto A; Ogawara KI; Kimura T; Higaki K; Yutani R; Sakane T; Furubayashi T
Eur J Pharm Sci; 2018 May; 117():21-26. PubMed ID: 29410273
[TBL] [Abstract][Full Text] [Related]
17. Absorption across the nasal airway mucosa in house dust mite perennial allergic rhinitis.
Greiff L; Andersson M; Svensson J; Wollmer P; Lundin S; Persson CG
Clin Physiol Funct Imaging; 2002 Jan; 22(1):55-7. PubMed ID: 12003101
[TBL] [Abstract][Full Text] [Related]
18. Nasal absorption in the rat. III. Effect of lysophospholipids on insulin absorption and nasal histology.
Chandler SG; Thomas NW; Illum L
Pharm Res; 1994 Nov; 11(11):1623-30. PubMed ID: 7870681
[TBL] [Abstract][Full Text] [Related]
19. Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin.
Harris AS; Svensson E; Wagner ZG; Lethagen S; Nilsson IM
J Pharm Sci; 1988 May; 77(5):405-8. PubMed ID: 3411462
[TBL] [Abstract][Full Text] [Related]
20. The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models.
Baldwin PA; Klingbeil CK; Grimm CJ; Longenecker JP
Pharm Res; 1990 May; 7(5):547-52. PubMed ID: 2367323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
